EAM
CNMD icon

Eagle Asset Management’s CONMED CNMD Stock Holding History

Eagle Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.37M Buy
127,556
+18,545
+17% +$1.31M 0.05% 306
2024
Q2 		$7.3M Sell
109,011
-2,838
-3% -$207K 0.04% 340
2024
Q1 		$8.83M Sell
111,849
-89,605
-44% -$7.99M 0.04% 304
2023
Q4 		$22.1M Buy
201,454
+2,472
+1% +$256K 0.12% 178
2023
Q3 		$20.1M Buy
198,982
+80,036
+67% +$9.2M 0.12% 180
2023
Q2 		$16.2M Buy
118,946
+8,686
+8% +$1.06M 0.09% 200
2023
Q1 		$11.5M Buy
110,260
+3,864
+4% +$374K 0.07% 231
2022
Q4 		$9.55M Buy
106,396
+15,588
+17% +$1.29M 0.06% 244
2022
Q3 		$7.28M Sell
90,808
-355,547
-80% -$33.5M 0.05% 284
2022
Q2 		$42.7M Sell
446,355
-65,543
-13% -$7.87M 0.27% 129
2022
Q1 		$76M Sell
511,898
-4,327
-0.8% -$604K 0.39% 100
2021
Q4 		$74M Sell
516,225
-17,176
-3% -$2.43M 0.32% 121
2021
Q3 		$69.8M Sell
533,401
-27,256
-5% -$3.57M 0.32% 122
2021
Q2 		$77.1M Sell
560,657
-110,696
-16% -$15.2M 0.33% 117
2021
Q1 		$87M Buy
671,353
+22,003
+3% +$2.65M 0.39% 97
2020
Q4 		$72.7M Buy
649,350
+194,622
+43% +$18.4M 0.41% 84
2020
Q3 		$35.1M Sell
454,728
-2,388
-0.5% -$195K 0.18% 183
2020
Q2 		$31.7M Buy
457,116
+17,157
+4% +$1.19M 0.18% 177
2020
Q1 		$25.2M Buy
439,959
+31,464
+8% +$2.9M 0.16% 191
2019
Q4 		$45.7M Buy
408,495
+50,264
+14% +$5.36M 0.22% 173
2019
Q3 		$34.4M Buy
358,231
+236,680
+195% +$22.2M 0.18% 187
2019
Q2 		$10.4M Buy
121,551
+28,800
+31% +$2.37M 0.05% 302
2019
Q1 		$7.71M Buy
+92,751
New +$6.74M 0.04% 341
2014
Q3 		– Sell
-309,020
Closed -$13.6M – 625
2014
Q2 		$13.6M Sell
309,020
-9,944
-3% -$451K 0.07% 294
2014
Q1 		$13.9M Buy
+318,964
New +$14.2M 0.08% 303

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Eagle Asset Management's CNMD Position: Q3 2024 in Review

Eagle Asset Management increased its CONMED (CNMD) stake by 17% in Q3 2024, buying an estimated $1.31M and bringing the position to 127,556 shares worth $9.37M. The position accounts for 0.05% of the portfolio, ranked #306.

Eagle Asset Management first reported a position in CNMD in Q1 2014 and has held it in 25 quarters since. The position peaked at $87M in Q1 2021. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Eagle Asset Management held 127,556 shares of CONMED worth $9.37M as of Q3 2024.
  • Eagle Asset Management bought 18,545 CONMED shares in Q3 2024, an estimated $1.31M.
  • CONMED made up 0.05% of Eagle Asset Management's portfolio in Q3 2024, its #306 holding.
  • Eagle Asset Management first reported a position in CONMED in Q1 2014 and has held it in 25 quarters since.
  • Eagle Asset Management's CONMED position peaked at $87M in Q1 2021.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.